Hematology & Oncology Doctors in Fort Sam Houston, TX Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Dr. Charles Edward Jacocks, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4808    Fax: 908-282-3289

Dr. Thomas Joseph Richard, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3851 Roger Brooke Drive, Mche-qd (credentials), Fort Sam Houston, TX 78234 Phone: 210-916-0504

Dr. Angela Gowdy Mysliwiec, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Drive, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-295-6239

News Archive

People with normal blood sugar range may be at increased risk of brain shrinkage

People whose blood sugar is on the high end of the normal range may be at greater risk of brain shrinkage that occurs with aging and diseases such as dementia, according to new research published in the September 4, 2012, print issue of Neurology-, the medical journal of the American Academy of Neurology.

British tourist in Hong Kong has mad cow disease

A British tourist in Hong Kong has been struck down with what appears to be mad cow disease.

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

Medical physicists converge at ProCure TDC for training in physics of protons and proton therapy

Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

Scientists have uncovered the identity of the last of eight genes known to contribute to Bardet-Biedl syndrome

The identification of the BBS3 gene ends the search for primary BBS-causing genes in families studied for years by a team of scientists from the United States, Canada and the United Kingdom. However, the scientists are still hunting for other, less obvious genetic influences in these families.

Read more Medical News

› Verified 9 days ago